<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Complement-fixing antibodies against an antigen prepared from the EB3 line of cultured <z:e sem="disease" ids="C0006413" disease_type="Neoplastic Process" abbrv="BL">Burkitt tumour</z:e> cells were studied in various groups of patients and control individuals </plain></SENT>
<SENT sid="1" pm="."><plain>Higher antibody titres were observed in patients with <z:e sem="disease" ids="C0006413" disease_type="Neoplastic Process" abbrv="BL">Burkitt's tumour</z:e> than in African patients with other diagnoses </plain></SENT>
<SENT sid="2" pm="."><plain>Significantly more medical students and nurses with a history of <z:e sem="disease" ids="C0021345" disease_type="Disease or Syndrome" abbrv="">infectious mononucleosis</z:e> possessed antibodies than those with no such history </plain></SENT>
<SENT sid="3" pm="."><plain>Low levels of antibody were observed in patients during the <z:hpo ids='HP_0011009'>acute</z:hpo> phase of <z:e sem="disease" ids="C0021345" disease_type="Disease or Syndrome" abbrv="">infectious mononucleosis</z:e> and these levels were significantly lower than those in patients admitted to the same hospital with other diagnoses </plain></SENT>
<SENT sid="4" pm="."><plain>During the early months following the <z:hpo ids='HP_0011009'>acute</z:hpo> phase of illness, EB complement-fixing antibodies remained stationary or apparently declined in titre but, in patients tested one or more years later, significantly higher antibody levels were observed </plain></SENT>
</text></document>